Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019

BACKGROUND: With the global spread of coronavirus disease 2019 (COVID-19), an increasing number of clinical trials are being designed and executed to evaluate the efficacy and safety of various therapies for COVID-19. We conducted this survey to assess the methodological quality of registry protocol...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiaxing, Lu, Yiling, Kwong, Joey Sum-wing, Li, Xiaosi, Zheng, Wenyi, He, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481475/
https://www.ncbi.nlm.nih.gov/pubmed/32973535
http://dx.doi.org/10.3389/fphar.2020.01330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481475/
https://www.ncbi.nlm.nih.gov/pubmed/32973535
http://dx.doi.org/10.3389/fphar.2020.01330

Ejemplares similares